BERGAMINI, ALICE
 Distribuzione geografica
Continente #
EU - Europa 600
NA - Nord America 446
AS - Asia 310
OC - Oceania 10
SA - Sud America 6
Totale 1.372
Nazione #
US - Stati Uniti d'America 438
SE - Svezia 218
IT - Italia 197
CN - Cina 153
SG - Singapore 115
RU - Federazione Russa 101
DE - Germania 17
IE - Irlanda 16
FI - Finlandia 14
IN - India 13
NL - Olanda 10
FR - Francia 8
AT - Austria 6
AU - Australia 6
JP - Giappone 6
ID - Indonesia 5
PK - Pakistan 5
CA - Canada 4
GB - Regno Unito 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
IL - Israele 3
MX - Messico 3
PL - Polonia 3
AR - Argentina 2
BR - Brasile 2
IR - Iran 2
JO - Giordania 2
PE - Perù 2
BE - Belgio 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
GR - Grecia 1
PA - Panama 1
PH - Filippine 1
TR - Turchia 1
Totale 1.372
Città #
Milan 81
Singapore 78
Shanghai 61
New York 58
Ashburn 49
Lawrence 46
Princeton 46
Moscow 35
Boardman 33
Vaprio d'Adda 25
Dallas 16
Dublin 16
Seattle 13
Helsinki 11
Los Angeles 10
Pune 10
St Petersburg 10
Rome 7
Dalmine 5
Florence 5
Guangzhou 5
Shenzhen 5
Al Qatif 4
Beijing 4
Boston 4
Como 4
Munich 4
Pesaro 4
Azcapotzalco 3
Bandung 3
Chapel Hill 3
Gatchina 3
Hadera 3
Lappeenranta 3
Lissone 3
Maarheeze 3
Meda 3
Noisy-le-Grand 3
Osimo 3
Peshawar 3
Philadelphia 3
Warsaw 3
Xi'an 3
Yekaterinburg 3
Amman 2
Baronissi 2
Benevento 2
Borås 2
Brescia 2
Burnaby 2
Cambridge 2
Castenaso 2
Falkenstein 2
Fano 2
Fiesole 2
Francisco Santos 2
Genova 2
Higashihagoromo 2
Hyderabad 2
Inman 2
Innsbruck 2
Jiaxing 2
Jiyuan 2
Lima 2
Linz 2
London 2
Los Banos 2
Lower Hutt 2
Malé 2
Manerbio 2
Melbourne 2
Naaldwijk 2
Nizhniy Novgorod 2
Nuremberg 2
Paderno Franciacorta 2
Padova 2
Palo Alto 2
Pekalongan 2
Perugia 2
Quanzhou 2
Rockville 2
Roseto degli Abruzzi 2
Rozzano 2
San Jose 2
Santa Clara 2
Somerville 2
Strasbourg 2
Tehran 2
Toronto 2
Turin 2
Venice 2
Vienna 2
Vijayawada 2
Voronezh 2
Washington 2
West Lafayette 2
Adelaide 1
Amsterdam 1
Arlington 1
Auckland 1
Totale 805
Nome #
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 110
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 49
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 42
Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can! 37
A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. 35
Tumori del trofoblasto di origine gestazionale: impatto psicologico e ruolo dei meccanismi di difesa nel percorso di malattia 32
Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes 30
A Pictorial Ultrasound Essay of Gestational Trophoblastic Disease 29
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 28
Chemotherapy-Induced Nausea and Vomiting in Women With Gynecological Cancer: A Preliminary Single-Center Study Investigating Medical and Psychosocial Risk Factors 25
Chemotherapy-induced nausea in a sample of gynaecological cancer patients: assessment issues and personal risk factors evaluation 25
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 24
A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach 24
Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes 23
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 23
Illness Perception in Gestational Trophoblastic Disease Patients: How Mental Representations Affect Anxiety, Depression, and Infertility-Related Stress 23
Psychological factors influencing emotional reactions to gestational trophoblastic disease: The role of coping mechanisms and illness perception 23
Gestational Trophoblastic Disease: the effect of mental representations on anxiety, depression, and infertility-related stress 21
[Anti-angiogenic drugs and hypertension: from multidisciplinary collaboration to greater care] 20
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study 20
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 19
Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study 19
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 19
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study 19
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 18
Do stage and grade of malignancy impact fertility preservation in breast cancer patients? 18
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin 18
Fertility sparing surgery in epithelial ovarian cancer in Italy: perceptions, practice, and main issues 18
Factors Associated With a High Motivation to Undergo Fertility Preservation in Female Cancer Patients 18
Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study 18
Socio-demographic and psychological factors associated with quality of life of women undergoing chemotherapy treatment for gynecological cancer 18
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study 17
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 17
A prospective, observational study of chemotherapy-induced ovarian damage on follicular reserve and maturation 17
Contrast-enhanced ultrasound for ovary assessment in a murine model: preliminary findings on the protective role of a gonadotropin-releasing hormone analogue from chemotherapy-induced ovarian damage 17
What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome 17
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 17
Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience 16
Quality of life and chemotherapy: Predictive factors in a sample of gynaecological cancer patients 16
Psychological aspects and fertility issues of GTD 16
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 15
Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN) 15
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 15
Inhibition of Phosphodiesterase 4 Enhances Clitoral and Vaginal Blood Flow Responses to Dorsal Clitoral Nerve Stimulation or PGE1 in Anesthetized Female Rats 15
Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis 14
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 14
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 14
Carboplatin Use in Pregnancy for Stage IB3 Cervical Cancer: Case Report and Review of the Literature 14
Ovarian failure risk in post-pubertal patients with cancer: a prognostic model 14
Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26) 14
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 14
Reply to "Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?". 14
Pelvic nerve injury negatively impacts female genital blood flow and induces vaginal fibrosis-implications for human nerve-sparing radical hysterectomy 14
Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy. 14
Role of Surgery in the Management of Hydatidiform Mole in Elderly Patients: A Single-Center Clinical Experience 14
Small Cell Carcinoma of the Ovary: Report of Three Cases of a Poor Prognosis Disease 13
Hydatidiform mole: age-related clinical presentation and high rate of severe complications in older women 13
Different Patterns of Disease Spread between Advanced-Stage Type i and II Epithelial Ovarian Cancer 13
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 12
Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery 12
Mental Representations of Illness in Patients with Gestational Trophoblastic Disease: How Do Patients Perceive Their Condition? 12
Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time? 12
Reproductive outcomes after gestational trophoblastic neoplasia. A comparison between single-agent and multiagent chemotherapy: Retrospective analysis from the MITO-9 group 12
Transvaginal ultrasound in evaluation and follow-up of ovarian granulosa cell tumors 12
Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison 11
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 11
Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer 11
Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas. 11
Neoadjuvant chemotherapy in high-risk ovarian cancer patients: Role of age 11
Psychological Aspects Associated With Fertility Preservation in Oncology: An Exploratory Study 11
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial 10
Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence 10
Correction to: A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach (CVIR Endovascular, (2018), 1, 1, (30), 10.1186/s42155-018-0039-8) 10
Endometriosis-associated tumor at the inguinal site: report of a case diagnosed during pregnancy and literature review 10
Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors 10
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 10
Perioperative Betamethasone Treatment Reduces Signs of Bladder Dysfunction in a Rat Model for Neurapraxia in Female Urogenital Surgery 10
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 10
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 9
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study 9
Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis 9
Survival in clinical stage I endometrial cancer with single vs. multiple positive pelvic nodes: results of a multi-institutional Italian study 8
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 8
Ovarian endometrioma: what the patient needs 8
Management of recurrent ovarian cancer: When platinum-based regimens are not a therapeutic option 8
Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease 7
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 6
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 6
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors 6
Fertility preservation in women with cervical cancer 6
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study 5
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 5
Totale 1.566
Categoria #
all - tutte 20.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 6 0 0 0 1
2020/202120 0 2 5 2 0 3 4 4 0 0 0 0
2021/202238 0 1 1 7 0 1 7 7 3 4 7 0
2022/2023622 107 78 25 10 8 42 185 58 48 16 39 6
2023/2024500 17 23 62 54 57 89 11 59 10 18 26 74
2024/2025351 141 35 64 51 60 0 0 0 0 0 0 0
Totale 1.566